Find a trial

At Icon, we offer clinical trials across various tumour types and blood disorders, allowing patients access to new and emerging advances in treatment. Find a trial that might be suitable for you.


Use the search function below to find a clinical trial that may suit you and your cancer diagnosis

+ Advanced

LIQUIK-01

Liquid Biopsy for Detection of Actionable Genomic Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer

Locations

Diagnosis

Lung cancer

Open for recruitment
Lihat Trial

REGENERON_ R1979-ONC-1625

An open-label study to assess the anti-tumor activity and safety of REGN1979, an Anti-CD20 X Anti-CD3 bispecific antibody, in patients with relapsed or refractory follicular lymphoma

Locations

Farrer Park

Diagnosis

Lymphoma – B-cell Non Hodgkin’s

Open for recruitment
Lihat Trial

TROPiCS-04

A Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician’s Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial Cancer.

Locations

hobart, wesley, adelaide

Diagnosis

Urothelial cancer

Open for recruitment
Lihat Trial

KRYSTAL-12

A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

Locations

Farrer Park

Diagnosis

Lung cancer

Open for recruitment
Lihat Trial

ASPEN 06

A Phase 2/3 Study of Evorpacept (ALX148) in Patients With Advanced HER2-Overexpressing Gastric/Gastroesophageal Junction Adenocarcinoma (ASPEN-06)

Locations

Farrer Park

Diagnosis

Gastric / gastroesophageal cancer

Open for recruitment
Lihat Trial

D9673R00005 HER 2 Real SGD 6603

A Multicountry, Multicentre, Noninterventional Retrospective Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer

Locations

Farrer Park

Diagnosis

Breast cancer

Open for recruitment
Lihat Trial

KRYSTAL-10

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation

Locations

Farrer Park

Diagnosis

Colorectal cancer

Open for recruitment
Lihat Trial

IMMU-132-13

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer

Locations

Farrer Park

Diagnosis

Bladder cancer

Open for recruitment
Lihat Trial

DESTINY

A Phase 3, randomised, multi-center, open-label study of Trastuzumab Derutecan ( T-DXd) vs investigator’s choice chemotherpy in HER2-low , hormone receptor positive breast cancer patients whose disease progressed on endocrine therapy in the metastatic setting

Locations

Gleneagles

Diagnosis

Breast cancer

Open for recruitment
Lihat Trial

Tropion 01 DS1602-A-U301

A Phase 3 Randomized Study of DS-1062A Versus Docetaxel In previously treated advanced or metastatic non-small cell lung cancer without actionable genomic alterations

Locations

Farrer Park

Diagnosis

Lung cancer

Open for recruitment
Lihat Trial

INSIGHT 2

A Phase II, two‑arm study to investigate Tepotinib combined with osimertinib in MET amplified, advanced or metastatic non-small cell lung cancer (NSCLC) harboring activating EGFR mutations and having acquired resistance to prior osimertinib therapy

Locations

Farrer Park

Diagnosis

Lung cancer

Recruitment completed
Lihat Trial

Y-mAbs 202

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients with High-Risk Neuroblastoma in First Remission. An International, Open-Label, Uncontrolled, Single-Arm, Multicenter, Phase 2 Trial

Locations

Mount Alvernia

Diagnosis

Neuroblastoma

Recruitment completed
Lihat Trial

CAPItello-290

A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastatic Triple-Negative Breast Cancer (TNBC)

Locations

Farrer Park

Diagnosis

Breast cancer

Recruitment completed
Lihat Trial

CheckMate 74W

A Randomized, Multi-center, Double-blinded, Placebo-controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination with Trans-arterial ChemoEmbolization (TACE) in Patients with Intermediate-stage Hepatocellular Carcinoma (HCC)

Locations

Farrer Park

Diagnosis

Liver cancer

Recruitment completed
Lihat Trial

Y-mAbs 203

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor in Combination with Irinotecan and Temozolomide in Patients with High-Risk Neuroblastoma with Primary Refractory Disease or in First Relapse. An International, Single-Arm, Multicenter Phase 2 Trial

Locations

Mount Alvernia

Diagnosis

Neuroblastoma

Recruitment completed
Lihat Trial

SKYSCRAPER-08 YO42138

A phase III, randomized, double-blind, placebo-controlled study of Tiragolumab Plus Atezolizumab in combination with Cisplatin and Paclitaxel as first line treatment in patients with unresectable, locally advanced recurrent or metastatic Esophageal Squamous Carcinoma.

Locations

Farrer Park

Diagnosis

Gastric / gastroesophageal cancer

Recruitment completed
Lihat Trial

CBYL719X2402 BYLieve

A phase 2, multicenter, open-label, three-cohort, non-comparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant, hormone receptor (HR+) positive, HER2-negative advanced breast cancer (aBC), who have progressed on or after prior treatments

Locations

Farrer Park

Diagnosis

Breast cancer

Recruitment completed
Lihat Trial

CLEE011A3201C RIGHT CHOICE

A phase 2, randomized study of the combination of ribociclib plus goserelin acetate with hormonal therapy vs physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor-positive/HER2-negative inoperable locally advanced or metastatic breast cancer

Locations

Farrer Park

Diagnosis

Breast cancer

Recruitment completed
Lihat Trial

We are always introducing new clinical trials across our international network. If you can’t find what you are looking for please don’t hesitate to speak to your doctor to learn more, or contact us here.

Cari